FrancophonIA/ELRC3.0 huggingface dataset:
English: Similar to other beta-lactam antibacterial agents, the time that meropenem concentrations exceed the MIC (T>MIC) has been shown to best correlate with efficacy.
Slovenian: Podobno kot velja za druga betalaktamska protimikrobna zdravila, je tudi za meropenem dokazano, da z njegovo učinkovitostjo korelira čas, med katerim koncentracija meropenema presega MIK
English: MIC summary data for the common gynaecological pathogens isolated from the clinical study presented in the original MAA are presented
Slovenian: Predstavljen je povzetek podatkov o MIC za splošne ginekološke patogene, ki so jih izolirali iz klinične študije in so bili predstavljeni v izvirni vlogi za dovoljenje za promet z zdravilom.
English: • Use the medicine straight after preparing it. Do not freeze it. How to prepare this medicine 1.
Slovenian: • Zdravilo morate uporabiti, takoj ko ga pripravite.
English: Meronem and associated names (see Annex I) 500 mg powder for solution for injection or infusion Meronem and associated names (see Annex I) 1 g powder for solution for injection or infusion
Slovenian: Meronem in povezana imena (glejte Dodatek I) 500 mg prašek za raztopino za injiciranje ali infundiranje Meronem in povezana imena (glejte Dodatek I) 1 g prašek za raztopino za injiciranje ali infundiranje
English: Romania: Meronem i.v.
Slovenian: Romunija: Meronem i.v.
English: • Diarrhoea.
Slovenian: • Mravljinčenje.
English: With the plunger of the syringe pushed fully into the syringe, put the needle back through the grey rubber stopper.
Slovenian: Preverite, ali je bat brizge potisnjen do konca v brizgo; iglo znova zabodite skozi sivi gumijasti zamašek.
English: Regarding the paediatric population, the CHMP is in agreement with the MAH to mention “3 months” as the lower limit of age but considers that the option of treating children under 3 months including neonates should be retained.
Slovenian: Kar se tiče pediatrične populacije, se CHMP strinja z imetnikom dovoljenja za promet z zdravilom, da je treba omeniti „tri mesece“ kot spodnjo starostno mejo, vendar meni, da je treba ohraniti možnost zdravljenja otrok, mlajših od treh mesecev, vključno z novorojenčki.
English: Uncommon blood bilirubin increased
Slovenian: Občasni zvišanje bilirubina v krvi
English: Children from 3 months to 11 years of age and up to 50 kg body weight The recommended dose regimens are shown in the table below:
Slovenian: Otroci, stari od 3 mesecev do 11 let in s telesno maso do 50 kg
English: However, the interest to use carbapenems including meropenem in cSSSI is now supported by the clinical experience.
Slovenian: Vendar pa je podpora za uporabo karbapenemov, vključno z meropenemom za zapletene okužbe kože in kožnih struktur, zdaj potrjena s kliničnimi izkušnjami.
English: Regarding the paediatric population, the CHMP agreed with the MAH to mention “3 months” as the lower limit of age but considered that the option of treating children under 3 months including neonates should be retained.
Slovenian: Glede pediatrične populacije, se je CHMP strinjal z imetnikom dovoljenja za promet z zdravilom, da je treba omeniti „tri mesece“ kot spodnjo starostno mejo, vendar je menil, da je treba ohraniti možnost zdravljenja otrok, mlajših od treh mesecev, vključno z novorojenčki.
English: AstraZeneca Kft. H-2045 Törökbálint Park u. 3.
Slovenian: Madžarska AstraZeneca Kft. - Hungary H-2045 Törökbálint
English: Additional modifications mentioning the effects on the CNS in rodents were also added to section 5.3 of the SPC.
Slovenian: Poglavju 5.3 povzetka glavnih značilnosti zdravila so bile dodane tudi spremembe, ki omenjajo učinke na osrednji živčni sistem glodalcev.
English: - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
Slovenian: - Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali medicinsko sestro.
English: Netherlands: Meronem i.v.
Slovenian: Nizozemska: Meronem i.v.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL (VIAL)
Slovenian: PODATKI NA PRIMARNI OVOJNINI NALEPKA (VIALA)
English: (Invented) name Strength Pharmaceutical Form Route of administration
Slovenian: Izmišljeno ime promet z zdravilom
English: The MAH also searched the patient safety database for cases with a medical history of CF. A total of 484 events were identified in 273 cases, which were summarised and discussed by the MAH.
Slovenian: Skupaj je odkril 484 dogodkov v 273 primerih, ki jih je povzel in o njih razpravljal.
English: Place a new clean cap on your central line and carefully throw the syringe away in your sharps bin.
Slovenian: Na centralni kanal namestite novo, čisto zaporko in brizgo previdno odvrzite v vsebnik za ostre odpadke.
English: Marketing Authorisation Holder
Slovenian: Imetnik dovoljenja za
English: Caution is required if probenecid is co-administered with meropenem.
Slovenian: V primeru sočasne uporabe probenecida in meropenema je potrebna previdnost.
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally] {Name }
Slovenian: IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM [glejte Dodatek I - Izpolni država članica]
English: Each vial contains meropenem trihydrate equivalent to 500 mg anhydrous meropenem.
Slovenian: Ena viala vsebuje meropenem trihidrat, kolikor ga ustreza 500 mg brezvodnega meropenema.
English: LIST OF EXCIPIENTS Anhydrous sodium carbonate.
Slovenian: SEZNAM POMOŽNIH SNOVI Brezvodni natrijev karbonat.
English: Pharmacotherapeutic group: antibacterials for systemic use, carbapenems, ATC code: J01DH02
Slovenian: Oznaka ATC: J01DH02
English: The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections.
Slovenian: Prevalenca pridobljene odpornosti pri določenih vrstah se lahko spreminja geografsko in s časom.
English: The MAH also listed the pathogens relevant to IAI, including MIC summary data for the common IAI pathogens isolated from the clinical studies.
Slovenian: Imetnik dovoljenja za promet z zdravilom je navedel tudi povzročitelje bolezni, ki so pomembni za intraabdominalne okužbe, vključno s povzetkom podatkov o MIC za splošne povzročitelje intraabdominalnih okužb, ki so jih izolirali iz kliničnih študij.
English: A dose of up to 2 g three times daily in adults and adolescents and a dose of up to 40 mg/kg three times daily in children may be particularly appropriate when treating some types of infections, such as nosocomial infections due to Pseudomonas aeruginosa or Acinetobacter spp.
Slovenian: Za zdravljenje nekaterih okužb, npr. v bolnišnici dobljenih okužb s Pseudomonas aeruginosa ali Acinetobacter spp., je lahko za odrasle in mladostnike posebno primeren odmerek do 2 g trikrat na dan in za otroke odmerek do 40 mg/kg trikrat na dan.
English: • Broncho-pulmonary infections in cystic fibrosis
Slovenian: • bronhopulmonalnih okužb pri cistični fibrozi,
English: 1 g/100 ml (not marketed)
Slovenian: 1 g/100 ml (se ne trži)
English: For the indication acute bacterial meningitis the CHMP agreed with the MAH proposal concerning the dosage regimen including exclusively higher doses of 2 g to be administered every 8 hours for both adults and adolescents, and children over 50 kg body weight.
Slovenian: Za indikacijo akutnega bakterijskega meningitisa se je CHMP strinjal s predlogom imetnika dovoljenja za promet z zdravilom glede režima odmerjanja, v katerega so bili vključeni samo odmerki, večji od 2 g, ki jih je treba dajati vsakih 8 ur odraslim, mladostnikom in otrokom s telesno maso nad 50 kg. Za otroke od 3 mesecev (in mlajših) do 11 let starosti in s telesno maso do 50 kg, se je Odbor strinjal z odmerkom 40 mg/kg, ki se daje vsakih 8 ur.
English: Each vial contains meropenem trihydrate equivalent to 1 g anhydrous meropenem.
Slovenian: Ena viala vsebuje meropenem trihidrat, kolikor ga ustreza 1 g brezvodnega meropenema.
English: The clinical programme submitted at the time of the original MAA application described 1 clinical study in 40 patients, of which 27 were treated with meropenem.
Slovenian: Klinični program, ki je bil predložen v času izvirne vloge za odobritev dovoljenja za promet z zdravilom, je opisoval eno klinično študijo pri 40 bolnikih, od katerih so jih 27 zdravili z zdravilno učinkovino meropenem.
English: What Meronem contains
Slovenian: Kaj vsebuje zdravilo Meronem
English: This may be associated with a high fever and joint pains.
Slovenian: Spremljajo jih lahko zvišana telesna temperatura in bolečine v sklepih.
English: Consequently the CLSI paragraph was deleted and only EUCAST information was specified for this harmonised EU SPC.
Slovenian: CLSI, v povzetku glavnih značilnosti zdravila, ki je usklajen v EU, pa so ohranjene samo informacije, ki se nanašajo na EUCAST.
English: Hepatic impairment No dose adjustment is necessary in patients with hepatic impairment (see section 4.4).
Slovenian: Bolnikom z okvaro jeter odmerka ni treba prilagoditi (glejte poglavje 4.4).
English: Meronem 500 mg: anhydrous sodium carbonate Meronem 1 g: anhydrous sodium carbonate
Slovenian: Meronem 500 mg: brezvodni natrijev karbonat
English: It is recommended that the INR should be monitored frequently during and shortly after coadministration of antibiotics with an oral anti-coagulant agent.
Slovenian: Med sočasno uporabo antibiotikov in katerega od peroralnih antikoagulansov ter krajši čas po takšni uporabi je priporočljivo pogosto kontrolirati INR.
English: Close the cap of your cannula and carefully throw the syringe away in your sharps bin.
Slovenian: Zaprite zaporko kanile in brizgo previdno odvrzite v vsebnik za ostre odpadke.
English: The clinical programme submitted at the time of the original MAA application describes 4 clinical studies in approximately 220 patients with meningitis infections, of which approximately 120 were treated with meropenem.
Slovenian: Klinični program, ki je bil predložen v času izvirne vloge za odobritev dovoljenja za promet z zdravilom, je opisoval štiri klinične študije pri približno 220 bolnikih z meningitisom, od katerih so jih približno 120 zdravili z meropenemom.
English: Meronem 500mg prasek za raztopino za injiciranje ali infundiranje
Slovenian: Meronem 500mg prašek za raztopino za injiciranje ali infundiranje
English: Ireland: Meronem IV
Slovenian: Irska: Meronem IV
English: Iceland: Meronem
Slovenian: Islandija: Meronem
English: France: MERONEM
Slovenian: Francija: MERONEM
English: The clinical programme submitted at the time of the original MAA application described 6 clinical studies in approximately 1200 patients, of which approximately 650 were treated with meropenem.
Slovenian: Klinični program, ki je bil predložen v času izvirne vloge za odobritev dovoljenja za promet z zdravilom, je opisoval šest kliničnih študij pri približno 1 200 bolnikih, od katerih so jih približno 650 zdravili z zdravilno učinkovino meropenem.
English: Spain: Meronem I.V.
Slovenian: Španija: Meronem I.V.
English: • Abdominal (stomach) pain.
Slovenian: • Bolečine v trebuhu.
English: Marketing Authorisation Holder and Manufacturer [See Annex I - To be completed nationally]
Slovenian: Izdelovalec [glejte Dodatek I - Izpolni država članica]
English: Belgium: Meronem IV
Slovenian: Belgija: Meronem IV
English: Pneumonia including community-acquired pneumonia and nosocomial pneumonia
Slovenian: Pljučnica, vključno z izvenbolnišnično pridobljeno pljučnico in bolnišnično pridobljeno pljučnico
English: The other ingredient is anhydrous sodium carbonate
Slovenian: Pomožna snov je brezvodni natrijev karbonat.
English: The clinical programme submitted at the time of the original MAA application described 1 clinical study in approximately 500 patients with obstetric and gynaecological infections, of which approximately 250 were treated with meropenem.
Slovenian: Klinični program, ki je bil predložen v času izvirne vloge za odobritev dovoljenja za promet z zdravilom, je opisoval eno klinično študijo pri približno 500 bolnicah s porodniškimi in ginekološkimi okužbami, od katerih so jih približno 250 zdravili z meropenemom.
English: The clinical programme submitted at the time of the original MAA application described 2 clinical studies in approximately 470 patients, of which approximately 230 were treated with meropenem.
Slovenian: Klinični program, ki je bil predložen v času izvirne vloge za odobritev dovoljenja za promet z zdravilom, je opisoval dve klinični študiji pri približno 470 bolnikih, od katerih so jih približno 230 zdravili z zdravilno učinkovino meropenem.
English: PHARMACEUTICAL FORM AND CONTENTS
Slovenian: Jakost Farmacevtska oblika
English: Estonia: Meronem
Slovenian: Estonija: Meronem
English: Complicated skin and skin tissue infections
Slovenian: Zapletene okužbe kože in kožnih tkiv
English: Bulgaria: Meronem
Slovenian: Bolgarija: Meronem
English: Lithuania: Meronem IV
Slovenian: Litva: Meronem IV
English: • Feeling sick (nausea).
Slovenian: • Občutek slabosti (siljenje na bruhanje).
English: Luxembourg: Meronem IV
Slovenian: Luksemburg: Meronem IV
English: • Infections of the mouth or the vagina that are caused by a fungus (thrush).
Slovenian: • Glivične okužbe ust ali nožnice ("gobice").
English: The clinical programme submitted at the time of the original MAA application described 5 clinical studies in approximately 1150 patients with IAI, of which approximately 580 were treated with meropenem.
Slovenian: Klinični program, ki je bil predložen v času izvirne vloge za dovoljenje za promet z zdravilom, je opisoval 5 kliničnih študij pri približno 1 150 bolnikih z intraabdominalnimi okužbami, od katerih so jih približno 580 zdravili z zdravilno učinkovino meropenem.
English: Uncommon thrombophlebitis
Slovenian: Občasni tromboflebitis
English: The CHMP agreed with the statement proposed by the MAH.
Slovenian: CHMP se je strinjal predlogom imetnika dovoljenja za promet z zdravilom.
English: Latvia: Meronem
Slovenian: Latvija: Meronem
English: • Complicated skin and soft tissue infections
Slovenian: • Zapletene okužbe kože in mehkih tkiv
English: The MAH provided an overview of the pathogens relevant to LRTI, including MIC summary data for the common LRTI pathogens isolated.
Slovenian: Imetnik dovoljenja za promet z zdravilom je priskrbel pregled povzročiteljev bolezni, ki so pomembni za bolnike z okužbo spodnjih dihalnih poti, vključno s povzetkom podatkov o minimalni inhibitorni koncentraciji (MIC) za običajne izolirane povzročitelje bolezni, ki povzročajo okužbe spodnjih dihalnih poti.
English: • Skin rash, itchy skin.
Slovenian: • Izpuščaj na koži, srbeča koža.
English: Finland: Meronem
Slovenian: Finska: Meronem
English: Haemodialysis will remove Meronem and its metabolite.
Slovenian: S hemodializo se odstrani zdravilo Meronem in njegov presnovek.
English: Czech Republic: MERONEM
Slovenian: Češka: MERONEM
English: 250 mg/5 ml (not marketed)
Slovenian: 250 mg/5 ml (se ne trži)
English: Slovenia: Meronem
Slovenian: Slovenija: Meronem
English: Denmark: MERONEM
Slovenian: Danska: MERONEM
English: MERREM 250 mg Powder and solvent for solution for infusion
Slovenian: MERREM 250 mg polvere e solvente per soluzione per infusione
English: Greece: Meronem
Slovenian: Grčija: Meronem
English: 250 mg/100 ml (not marketed)
Slovenian: 250 mg/100 ml (se ne trži)
English: 500 mg/10 ml (not marketed)
Slovenian: 500 mg/10 ml (se ne trži)
English: Hungary: Meronem
Slovenian: Madžarska: Meronem
English: Portugal: Meronem
Slovenian: Portugalska: Meronem
English: United Kingdom: Meronem IV
Slovenian: Velika Britanija: Meronem IV
English: 500 mg/100 ml (not marketed)
Slovenian: 500 mg/100 ml (se ne trži)
English: Complicated skin and skin structure infections (cSSSI)
Slovenian: Zapletene okužbe kože in kožnih struktur
English: The clinical programme submitted at the time of the original MAA application described 6 clinical studies in approximately 950 patients with SSSIs, of which approximately 470 were treated with meropenem.
Slovenian: Klinični program, ki je bil predložen v času izvirne vloge za odobritev dovoljenja za promet z zdravilom, je opisoval šest kliničnih študij pri približno 950 bolnikih z zapletenimi okužbami kože in kožnih struktur, od katerih so jih približno 470 zdravili z meropenemom.
English: Renal and urinary disorders Uncommon blood creatinine increased, blood urea increased
Slovenian: Občasni zvišanje kreatinina v krvi, zvišanje sečnine v krvi
English: Norway: Meronem
Slovenian: Norveška: Meronem
English: • Pneumonia, including community acquired pneumonia and nosocomial pneumonia.
Slovenian: • pljučnice, vključno s pljučnico, dobljeno v domačem okolju, in pljučnico, dobljeno v bolnišnici,
English: • Complicated infections in the abdomen
Slovenian: • Zapletene okužbe v trebuhu
English: MERREM 500 mg Powder and solvent for solution for infusion
Slovenian: MERREM 500 mg polvere e solvente per soluzione per infusione
English: HOW TO STORE MERONEM
Slovenian: SHRANJEVANJE ZDRAVILA MERONEM
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each vial contains meropenem trihydrate equivalent to 500 mg anhydrous meropenem.
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena viala vsebuje meropenem trihidrat, kolikor ga ustreza 500 mg brezvodnega meropenema.
English: Poland: Meronem
Slovenian: Poljska: Meronem
English: Common diarrhoea, vomiting, nausea,
Slovenian: Pogosti driska, bruhanje, navzea, bolečine v trebuhu
English: It should be noted that considerations for cUTI are the same for adults and for children.
Slovenian: Treba je upoštevati, da so premisleki glede zapletenih okužb sečil enaki tako za odrasle kot za otroke.
English: 500 mg 500 mg Powder for solution for injection or infusion
Slovenian: 500 mg 500 mg Prašek za raztopino za injiciranje ali infundiranje
English: Sweden: Meronem
Slovenian: Švedska: Meronem
English: $Species that show natural intermediate susceptibility £All methicillin-resistant staphylococci are resistant to meropenem †Resistance rate ≥ 50% in one or more EU countries.
Slovenian: †Delež odpornosti ≥ 50 % v eni ali več državah EU.
English: Meronem I.V., 500 500 mg Powder for solution for injection or infusion
Slovenian: Meronem I.V., 500 500 mg Prašek za raztopino za injiciranje ali infundiranje
English: Consequently taking into account the microbiological activity of meropenem, the current microbiological context, the clinical practice, the medical need of penems in some situations, and the fact that meropenem is intended only in severe bacterial infections suspected or due to pathogens resistant to other beta-lactams and susceptible to meropenem, the CHMP considered the indication “acute bacterial meningitis” to be acceptable.
Slovenian: Zato je CHMP ob upoštevanju mikrobiološke aktivnosti meropenema, trenutnega mikrobiološkega konteksta, klinične prakse, medicinskih potreb po penemu v nekaterih okoliščinah in dejstva, da se meropenem lahko uporablja samo za resne bakterijske okužbe, ki jih povzročajo patogeni ali se domneva, da so jih povzročili patogeni, odporni na druge betalaktame, a občutljivi za meropenem, menil, da je naslednja indikacija „akutni bakterijski meningitis“ sprejemljiva.
English: 500mg Powder for solution for injection
Slovenian: 500mg Prašek za raztopino za injiciranje
English: MERONEM 500 mg Powder for solution for injection
Slovenian: MERONEM 500 mg Prašek za raztopino za injiciranje
English: Consequently, taking into account the microbiological activity of -penems, the current microbiological context, the clinical practice, the medical need of penems in some situations, and the fact that meropenem is intended only in severe bacterial infections suspected or due to pathogens resistant to other beta-lactams and susceptible to meropenem, the CHMP considered the following indication to be acceptable:
Slovenian: Zato je CHMP ob upoštevanju mikrobiološke aktivnosti penemov, trenutnega mikrobiološkega konteksta, klinične prakse, medicinskih potreb po penemu v nekaterih okoliščinah in dejstva, da se meropenem lahko uporablja samo za resne bakterijske okužbe, ki jih povzročajo patogeni ali se domneva, da so jih povzročili patogeni, odporni na druge betalaktame, a občutljivi za meropenem, menil, da je naslednja indikacija sprejemljiva:
English: Pneumonia, including community acquired pneumonia and nosocomial pneumonia
Slovenian: Pljučnica, vključno s pljučnico, dobljeno v domačem okolju, in pljučnico, dobljeno v bolnišnici
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Slovenian: Imetnik dovoljenja za promet z zdravilom
English: Meronem IV 500mg 500 mg Powder for solution for injection or infusion
Slovenian: Meronem IV 500mg 500 mg Prašek za raztopino za injiciranje ali infundiranje
English: Consequently taking into account the bacteria involved in this situation, the current microbiological context, the clinical practice, the medical need of penems in some cases, and the fact that meropenem is intended only in severe bacterial infections suspected or due to pathogens resistant to other beta-lactams and susceptible to meropenem, the CHMP considered that the indication for the treatment of febrile neutropenia could be accepted.
Slovenian: Zato je CHMP ob upoštevanju bakterij, ki so vključene v situacijo, trenutnega mikrobiološkega konteksta, klinične prakse, medicinskih potreb po penemu v nekaterih okoliščinah in dejstva, da se meropenem lahko uporablja samo za resne bakterijske okužbe, ki jih povzročajo patogeni ali se domneva, da so jih povzročili patogeni, odporni na druge betalaktame, a občutljivi za meropenem, menil, da je naslednja indikacija „zdravljenje febrilne nevtropenije“ sprejemljiva.
English: Consequently, taking into account the knowledge of the pharmacological class of -penems, the current microbiological context, the clinical practice and the clinical recommendations, the medical need of penems in some situations, and considering that meropenem should be used only in severe bacterial infections suspected or due to pathogens resistant to other beta-lactams and susceptible to meropenem, the CHMP considered that the following meropenem wording of the SPC therapeutic indication was acceptable:
Slovenian: Zato je CHMP ob upoštevanju farmakološkega razreda penemov, trenutnega mikrobiološkega konteksta, klinične prakse in kliničnih priporočil, medicinskih potreb po penemu v nekaterih okoliščinah in dejstva, da se meropenem lahko uporablja samo za resne bakterijske okužbe, ki jih povzročajo patogeni ali se domneva, da so jih povzročili patogeni, odporni na druge betalaktame, a občutljivi za meropenem, menil, da je naslednja indikacija za meropenem v povzetku glavnih značilnosti zdravila sprejemljiva:
English: Meronem IV 500mg 500mg Powder for solution for injection or infusion
Slovenian: Meronem IV 500mg 500mg Prašek za raztopino za injiciranje ali infundiranje
English: • Complicated urinary tract infections
Slovenian: • Zapletene okužbe sečil
English: Germany: Meronem
Slovenian: Nemčija: Meronem
English: Czech Republic AstraZeneca UK Ltd.
Slovenian: Češka republika AstraZeneca UK Ltd. Silk Road Business Park 1
English: Powder and solvent for solution for injection or infusion
Slovenian: Prašek in topilo za raztopino za injiciranje ali infundiranje
English: 500mg Powder for solution infusion
Slovenian: 500mg Prašek za raztopino za infundiranje
English: Meronem 500 mg 500 mg Powder for solution for injection or infusion
Slovenian: Meronem 500 mg 500 mg Prašek za raztopino za injiciranje ali infundiranje
English: STATEMENT OF ACTIVE SUBSTANCE(S) Meropenem trihydrate equivalent to 500 mg anhydrous meropenem Meropenem trihydrate equivalent to 1 g anhydrous meropenem
Slovenian: Meronem in povezana imena (glejte Dodatek I) 500 mg Ena viala vsebuje meropenem trihidrat, kolikor ga ustreza 500 mg brezvodnega meropenema.
English: Common
Slovenian: Ł
English: Meronem and associated names (see Annex I) 500 mg
Slovenian: Meronem in povezana imena (glejte Dodatek I) 500 mg prašek za raztopino za injiciranje ali infundiranje
English: This will help to protect against diseases caused by these viruses.
Slovenian: To prispeva k obrambi pred boleznimi, ki jih ti virusi povzročajo.
English: They should be re-vaccinated at between 12 and 15 months.
Slovenian: Ponovno cepljenje je treba opraviti v starosti od 12 do 15 mesecev.